Beijing QL Biopharmaceutical Co.,Ltd

Works in Metabolic & endocrine

Beijing QL Biopharmaceutical Co.,Ltd is a clinical trial sponsor. It has 8 active clinical trials with 1,385 planned participants, in Metabolic & endocrine. Since 2021 it has completed 5 trials and stopped 0 early.

Trial track record · since 2021

8Active trials1,385 planned participants
5Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 8 active trials

StageTrialStatus

Questions about Beijing QL Biopharmaceutical Co.,Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-04.

Approve Suite is not affiliated with Beijing QL Biopharmaceutical Co.,Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.